CONCORDBIO Share Price Target 2040

CAGR-based price projection for Concord Biotech Limited (CONCORDBIO) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (11.8% CAGR)
Rs 6,577
2040 Target
Base Case (29.6% CAGR)
Rs 51,725
2040 Target
Bull Case (88.3% CAGR)
Rs 9,676,304
2040 Target

Current Market Snapshot

CMP: Rs 1,374.10
52W High: Rs 1,587.50
52W Low: Rs 1,016.20
1Y CAGR: 67.9%
3Y CAGR: 29.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,537 Rs 1,781 Rs 2,587
2028 Rs 1,719 Rs 2,307 Rs 4,872
2029 Rs 1,922 Rs 2,990 Rs 9,173
2030 Rs 2,149 Rs 3,874 Rs 17,273
2031 Rs 2,404 Rs 5,021 Rs 32,523
2032 Rs 2,688 Rs 6,506 Rs 61,239
2033 Rs 3,006 Rs 8,431 Rs 115,309
2034 Rs 3,362 Rs 10,925 Rs 217,120
2035 Rs 3,760 Rs 14,157 Rs 408,822
2036 Rs 4,205 Rs 18,344 Rs 769,785
2037 Rs 4,702 Rs 23,771 Rs 1,449,453
2038 Rs 5,259 Rs 30,804 Rs 2,729,225
2039 Rs 5,881 Rs 39,916 Rs 5,138,950
2040 Rs 6,577 Rs 51,725 Rs 9,676,304

Other CONCORDBIO Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the CONCORDBIO share price target for 2040?

Based on historical growth analysis, the CONCORDBIO share price target for 2040 ranges from Rs 6,577 (conservative) to Rs 51,725 (base case) to Rs 9,676,304 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of CONCORDBIO?

The current market price of CONCORDBIO (Concord Biotech Limited) is Rs 1,374.10. The 52-week high is Rs 1,587.50 and 52-week low is Rs 1,016.20.

Is CONCORDBIO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for CONCORDBIO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 11.8% CAGR), Base (29.6% CAGR), and Bull (optimistic at 88.3% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.